Home Cytogen Dx

Cytogen Dx

acquired
Seed Round Financing
Genomic Diagnostics Technology Company

Basic Information

CymoGen Dx, LLC is a genomic diagnostic technology company that provides genomic reagents and fluorescence in situ hybridization (FISH) probe research products and solutions to clinical, biopharmaceutical, and research customers for the diagnosis and monitoring of cancer and human genetic diseases. It is dedicated to the development, manufacturing, and application of fluorescent DNA detection technology. The company offers tools to identify genomic aberrations in cancer cells found in tissue and bone marrow specimens. CymoGen Dx, LLC was formerly known as CymoGen, LLC. The company was founded in 2010 and is headquartered in New Windsor, New York.
Cytogen Dx Co.,Ltd
NewYork,United States of America
51~100 people
January 01, 2010
sales@cymogendx.com